Davide Guggi
Förmögenhet: - $ per 2026-06-30
Förmögenhet: - $ per 2026-06-30
Davide Guggi is the founder of Laevoroc Oncology AG, founded in 2019, holding the title of Chief Strategy Officer.
Dr. Guggi currently works at Helix BioPharma Corp.
as Chief Technology Officer since 2025.
Dr. Guggi holds a doctorate from the University of Vienna.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-05-21 | 0 ( -.--% ) | - $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| HELIX BIOPHARMA CORP. | Teknisk/Vetenskaplig/F&U Direktör | 2025-03-05 |
Laevoroc Oncology AG
Laevoroc Oncology AG BiotechnologyHealth Technology Develops and manufactures cancer immunotherapies | Grundare | 2019-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
| Privata företag | 3 |
|---|---|
Helix BioPharma Corp.
Helix BioPharma Corp. Pharmaceuticals: MajorHealth Technology Develops drugs for the prevention and treatment of cancer | Health Technology |
University of Vienna
University of Vienna Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Laevoroc Oncology AG
Laevoroc Oncology AG BiotechnologyHealth Technology Develops and manufactures cancer immunotherapies | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån